Skip to main content

Advertisement

Log in

TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27KIP1 protein

  • Original Article
  • Published:
Oncogene Submit manuscript

Abstract

Increasing evidence suggests that tissue inhibitor of metalloproteinases-1 (TIMP-1) can directly regulate cell growth and apoptosis independent of its matrix metalloproteinases (MMPs)-inhibitory activity. While TIMP-1's antiapoptotic activity has been well demonstrated, conflicting data has been reported regarding TIMP-1's role in growth regulation. Here we show that TIMP-1 reduces the growth rate of human breast epithelial (MCF10A) cells by inducing cell cycle arrest at G1. TIMP-1-mediated cell cycle arrest is associated with its downregulation of cyclin D1 and upregulation of p27KIP1, resulting in inhibition of cyclin-dependent kinase activity necessary for phosphorylation of the tumor suppressor retinoblastoma protein. We further show that TIMP-1 modulation of cyclin D1 and p27KIP1 is achieved through TIMP-1-mediated differential regulation of protein stability independent of growth factor signaling. We also show that TIMP-1-mediated differential regulation of cyclin D1 and p27KIP1 is independent of cell adhesion signaling. Whereas approximately 50% of MCF10A cells with reduced TIMP-1 expression underwent cell death following loss of cell adhesion (anoikis), TIMP-1 overexpressing cells remained viable with prominent cell cycle arrest without detectable cell death. Taken together, we propose that TIMP-1-mediated cell survival independent of cell adhesion is accompanied with cell cycle arrest in human breast epithelial cells, although cell cycle regulation may not be a prerequisite for TIMP-1 regulation of apoptosis in general.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

TIMP:

Tissue inhibitor of metalloproteinase

MMP:

matrix metalloproteinase

ECM:

extracellular matrix

CDKI:

cyclin-dependent kinase inhibitor

Rb:

retinoblastoma

ADAM:

a disintegrin and a metalloproteinase domain

AS:

antisense

mAb:

monoclonal antibody

pAb:

polyclonal antibody

rTIMP:

recombinant tissue inhibitor of metalloproteinase

FAK:

focal adhesion kinase

PI3-K:

phosphatidylinositol 3-kinase

ERKs:

extracellular signal-regulated kinases

EPA:

erythroid-potentiating activity

polyHEMA:

polyhydroxyethylmethacrylate

References

  • Alexander CM, Howard EW, Bissell MJ, Werb Z . (1996). J Cell Biol 135: 1669–1677.

  • Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC . (1988). Blood 71: 1720–1725.

  • Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ . (1989). Development 105: 223–235.

  • Bertaux B, Hornebeck W, Eisen AZ, Dubertret L . (1991). J Invest Dermatol 97: 679–685.

  • Chen J, Jackson PK, Kirschner MW, Dutta A . (1995). Nature 374: 386–388.

  • Damsky CH, Werb Z . (1992). Curr Opin Cell Biol 4: 772–781.

  • DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM . (1992). Cancer Res 52: 701–708.

  • Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ et al. (1985). Nature 318: 66–69.

  • Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA . (1993). Cell 73: 499–511.

  • Drubin DG, Nelson WJ . (1996). Cell 84: 335–344.

  • Dulbecco R, Allen WR, Bologna M, Bowman M . (1986). Cancer Res 46: 2449–2456.

  • Dulic V, Lees E, Reed SI . (1992). Science 257: 1958–1961.

  • Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R . (1999). Dev Biol 211: 238–254.

  • Fowlkes JL, Enghild JJ, Suzuki K, Nagase H . (1994). J Biol Chem 269: 25742–25746.

  • Frisch SM, Francis H . (1994). J Cell Biol 124: 619–626.

  • Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ et al. (1985). Nature 315: 768–771.

  • Golde DW, Bersch N, Quan SG, Lusis AJ . (1980). Proc Natl Acad Sci USA 77: 593–596.

  • Guedez L, Courtemanch L, Stetler-Stevenson M . (1998a). Blood 92: 1342–1349.

  • Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A et al. (1998b). J Clin Invest 102: 2002–2010.

  • Hatakeyama M, Brill JA, Fink GR, Weinberg RA . (1994). Genes Dev 8: 1759–1771.

  • Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K . (1992). FEBS Lett 298: 29–32.

  • Henriet P, Blavier L, Declerck YA . (1999). Apmis 107: 111–119.

  • Henriet P, Zhong ZD, Brooks PC, Weinberg KI, DeClerck YA . (2000). Proc Natl Acad Sci USA 97: 10026–10031.

  • Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA . (1992). Cell 70: 993–1006.

  • Juliano RL, Haskill S . (1993). J Cell Biol 120: 577–585.

  • Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S et al. (1992). Science 257: 1689–1694.

  • Lee SJ, Yoo HJ, Bae YS, Kim HJ, Lee ST . (2003). Biochem Biophys Res Commun 312: 1196–1201.

  • Lelievre S, Weaver VM, Bissell MJ . (1996). Recent Prog Horm Res 51: 417–432.

  • Li G, Fridman R, Kim HR . (1999). Cancer Res 59: 6267–6275.

  • Linette GP, Li Y, Roth K, Korsmeyer SJ . (1996). Proc Natl Acad Sci USA 93: 9545–9552.

  • Liotta LA, Steeg PS, Stetler-Stevenson WG . (1991). Cell 64: 327–336.

  • Liu XW, Bernardo MM, Fridman R, Kim HR . (2003). J Biol Chem 278: 40364–40372.

  • Liu XW, Taube ME, Jung KK, Dong Z, Lee YJ, Roshy S et al. (2005). Cancer Res 65: 898–906.

  • Luo Y, Hurwitz J, Massague J . (1995). Nature 375: 159–161.

  • Mazel S, Burtrum D, Petrie HT . (1996). J Exp Med 183: 2219–2226.

  • McCarthy K, Maguire T, McGreal G, McDermott E, O'Higgins N, Duffy MJ . (1999). Int J Cancer 84: 44–48.

  • Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U et al. (2005). Hepatology 41: 857–867.

  • Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA . (1994). Cancer Res 54: 5467–5473.

  • Motokura T, Arnold A . (1993). Curr Opin Genet Dev 3: 5–10.

  • Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ et al. (2002). J Biol Chem 277: 11069–11076.

  • O'Reilly LA, Huang DC, Strasser A . (1996). EMBO J 15: 6979–6990.

  • Porter JF, Shen S, Denhardt DT . (2004). Br J Cancer 90: 463–470.

  • Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O . (1997). Clin Cancer Res 3: 1623–1628.

  • Roskelley CD, Desprez PY, Bissell MJ . (1994). Proc Natl Acad Sci USA 91: 12378–12382.

  • Schmidt JW, Piepenhagen PA, Nelson WJ . (1993). Semin Cell Biol 4: 161–173.

  • Schrohl AS, Holten-Andersen MN, Peters HA, Look MP, Meijer-van Gelder ME, Klijn JG et al. (2004). Clin Cancer Res 10: 2289–2298.

  • Sherr CJ, Roberts JM . (1995). Genes Dev 9: 1149–1163.

  • Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW et al. (1999). Cell 98: 137–146.

  • Toyoshima H, Hunter T . (1994). Cell 78: 67–74.

  • Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA . (1996). J Biol Chem 271: 10079–10086.

  • Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ et al. (2003). J Cell Biol 162: 1123–1133.

  • Yoshiji H, Gomez DE, Thorgeirsson UP . (1996). Int J Cancer 69: 131–134.

  • Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T et al. (2002). Hepatology 36: 850–860.

Download references

Acknowledgements

This work is supported by NIH/National Cancer Institute Grant CA89113 (to H-R CK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H-R C Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taube, M., Liu, XW., Fridman, R. et al. TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27KIP1 protein. Oncogene 25, 3041–3048 (2006). https://doi.org/10.1038/sj.onc.1209336

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209336

  • Springer Nature Limited

Keywords

This article is cited by

Navigation